2019
Multivariate spatiotemporal modeling of drug- and alcohol-poisoning deaths in New York City, 2009–2014
Ransome Y, Subramanian SV, Duncan DT, Vlahov D, Warren J. Multivariate spatiotemporal modeling of drug- and alcohol-poisoning deaths in New York City, 2009–2014. Spatial And Spatio-temporal Epidemiology 2019, 32: 100306. PMID: 32007280, PMCID: PMC9996640, DOI: 10.1016/j.sste.2019.100306.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAlcoholismDrug OverdoseFemaleHumansMaleMultivariate AnalysisNew York CitySpatio-Temporal AnalysisUrban PopulationYoung AdultConceptsDrug-poisoning deathsMultivariate Poisson regression modelCurrent public health problemPublic health problemZip codesDrug overdose deathsCo-occurring epidemicsPublic health plannersPoisson regression modelsHigh prevalenceOverdose deathsHealth problemsHealth plannersHeavy drinkingDeathDrugsOutcomesRegression modelsPredictorsNew York CityIndividual-level predictorsPrevalenceYork City
2004
Acceptance and completion of hepatitis B vaccination among drug users in New York City.
Ompad D, Galea S, Wu Y, Fuller C, Latka M, Koblin B, Vlahov D. Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease And Public Health 2004, 7: 294-300. PMID: 15779793.Peer-Reviewed Original ResearchConceptsDrug usersVaccine acceptanceHepatitis B vaccination ratesNon-injecting drug usersDaily crack usersPrevious HBV infectionHepatitis B vaccinationB vaccination ratesOngoing prospective studyB vaccinationDaily injectorsHBV testingHBV vaccinationVaccination seriesVaccine acceptorsHBV infectionVaccine seriesPrevious vaccinationRisk behavior questionnaireProspective studyVaccination acceptanceVaccination ratesSerological evidenceSeries completionVaccinationGender, Social Support, and Posttraumatic Stress in Postwar Kosovo
Ahern J, Galea S, Fernandez W, Koci B, Waldman R, Vlahov D. Gender, Social Support, and Posttraumatic Stress in Postwar Kosovo. The Journal Of Nervous And Mental Disease 2004, 192: 762-770. PMID: 15505520, DOI: 10.1097/01.nmd.0000144695.02982.41.Peer-Reviewed Original ResearchConceptsPosttraumatic stress scoresPosttraumatic stress symptomsSocial supportStress scoresImportant public health effortsEmergency department studyEmergency department patientsMental health 2 yearsTraumatic eventsPublic health effortsLower posttraumatic stress scoresGreater protective effectStress symptomsLow social supportMore traumatic eventsDepartment patientsHigh prevalenceProtective effectHealth effortsHigher posttraumatic stress scoresDepartment studyMental healthWomenPosttraumatic stressSymptoms
2002
Prospective study of infective endocarditis among injection drug users
Wilson L, Thomas D, Astemborski J, Freedman T, Vlahov D. Prospective study of infective endocarditis among injection drug users. The Journal Of Infectious Diseases 2002, 185: 1761-1766. PMID: 12085322, DOI: 10.1086/340827.Peer-Reviewed Original ResearchConceptsInjection drug usersInfective endocarditisHIV-seronegative injection drug usersDrug usersHuman immunodeficiency virus (HIV) infectionCohort of IDUsInjection drug use behaviorsCD4 lymphocyte countImmunodeficiency virus infectionCase-control studyDrug use frequencyDrug use behaviorsHIV immunosuppressionLymphocyte countCase patientsHIV statusAlcohol intakeProspective studyInverse associationRisk factorsVirus infectionMultivariate analysisEndocarditisHIVIncidence
2001
Sexual Orientation and HIV Infection Prevalence among Young Latino Injection Drug Users in Harlem
Diaz T, Vlahov D, Greenberg B, Cuevas Y, Garfein R. Sexual Orientation and HIV Infection Prevalence among Young Latino Injection Drug Users in Harlem. Journal Of Women's Health 2001, 10: 371-380. PMID: 11445028, DOI: 10.1089/152460901750269698.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV infection prevalenceHIV infectionUnprotected sexHomosexual menDrug usersOlder injection drug usersHeterosexual menInfection prevalenceHIV infection ratesCohort studyHepatitis BAntibody testingWhole cohortSexual transmissionHigh prevalenceHigh riskOlder menHeterosexual womenLarger sample sizeDrug useInfection rateMultivariate analysisNew York CityYoung womenImprovement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy
Semba R, Shah N, Vlahov D. Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 315-319. PMID: 11317071, DOI: 10.1097/00126334-200104010-00003.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAnemiaAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBaltimoreBody Mass IndexCD4 Lymphocyte CountChronic DiseaseFemaleHemoglobinsHIV InfectionsHIV-1HumansLongitudinal StudiesMaleMultivariate AnalysisPrevalenceSex FactorsSubstance Abuse, IntravenousViral LoadConceptsInjection drug usersPlasma HIV loadActive antiretroviral therapyAntiretroviral therapyHIV loadOpportunistic infectionsCopies/Mean decreaseDrug usersHIV-positive injection drug usersPotent antiretroviral therapyImprovement of anemiaBody mass indexIncrease of hemoglobinAntiretroviral medicationsHIV infectionMass indexControl subjectsOverall prevalenceChronic diseasesAnemiaNutritional statusMean increaseMultivariate analysisHAARTMortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women: Longitudinal Analysis From the HIV Epidemiology Research Study
Ickovics J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Boland R, Moore J, Group F. Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women: Longitudinal Analysis From the HIV Epidemiology Research Study. JAMA 2001, 285: 1466-1474. PMID: 11255423, DOI: 10.1001/jama.285.11.1466.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusChronic depressive symptomsCD4 cell countHIV-seropositive womenTreatment of depressionDepressive symptomsCell countDisease progressionBaseline CD4 cell countCD4 cell count declineHIV Epidemiologic Research StudyCell count declineCD4 lymphocyte countBaseline viral loadEpidemiologic Studies Depression ScaleHIV disease progressionHIV Epidemiology Research StudyLongitudinal cohort studyEpidemiologic research studiesImpact of depressionAcademic medical centerSelf-reported CenterCohort studyLymphocyte countCount declineDynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users
Celentano D, Muñoz A, Cohn S, Vlahov D. Dynamics of behavioral risk factors for HIV/AIDS: a 6-year prospective study of injection drug users. Drug And Alcohol Dependence 2001, 61: 315-322. PMID: 11164696, DOI: 10.1016/s0376-8716(00)00154-x.Peer-Reviewed Original ResearchConceptsBehavioral risk factorsInjection drug usersProspective studyHIV transmissionRisk factorsDrug usersHIV behavioral risk factorsIncremental risk reductionHIV/AIDSRisk reductionHIV-seronegativesTime-dependent covariatesDrug injectorsHigh riskRisk behaviorsBehavioral risksBehavior changeRisky behaviorsRegression modelsLongitudinal predictorsRiskSeronegativesHIVAIDSAbstinenceFactors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City
Diaz T, Des Jarlais D, Vlahov D, Perlis T, Edwards V, Friedman S, Rockwell R, Hoover D, Williams I, Monterroso E. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal Of Public Health 2001, 91: 23-30. PMID: 11189819, PMCID: PMC1446499, DOI: 10.2105/ajph.91.1.23.Peer-Reviewed Original ResearchConceptsInjection drug usersYoung adult injection drug usersAdult injection drug usersHepatitis B virusDrug usersHCV infectionPrevalent hepatitis C virus infectionHepatitis C virus infectionYoung injection drug usersAnti-HCV positivityPrevalent HCV infectionPrevalent hepatitis CC virus infectionHIV serologyHCV antibodiesHepatitis CB virusVirus infectionDrug treatmentDrug useHCVNew York CitySex practicesInfectionUpper Manhattan
2000
HIV testing and retesting for men and women in Switzerland
Zwahlen M, Neuenschwander B, Jeannin A, Dubois-Arber F, Vlahov D. HIV testing and retesting for men and women in Switzerland. European Journal Of Epidemiology 2000, 16: 123-133. PMID: 10845261, DOI: 10.1023/a:1007638823567.Peer-Reviewed Original Research
1999
Differing Risk Factors for Cerebral Palsy in the Presence of Mental Retardation and Epilepsy
Arpino C, Curatolo P, Stazi M, Pellegri A, Vlahov D. Differing Risk Factors for Cerebral Palsy in the Presence of Mental Retardation and Epilepsy. Journal Of Child Neurology 1999, 14: 151-155. PMID: 10190264, DOI: 10.1177/088307389901400303.Peer-Reviewed Original ResearchConceptsCerebral palsyDiagnosis groupsMental retardationDual diagnosis groupHistory of epilepsyFirst-degree relativesGestational ageSevere manifestationsRisk factorsEtiopathogenetic pathwaysPalsyMother's ageNeonatal convulsionsMaternal educationEpilepsyOverlapping outcomesAgeRetardationChildrenGroupBirthweightConvulsionsYearsDiagnosisWeeks
1998
Self-reported Antiretroviral Therapy in Injection Drug Users
Celentano D, Vlahov D, Cohn S, Shadle V, Obasanjo O, Moore R. Self-reported Antiretroviral Therapy in Injection Drug Users. JAMA 1998, 280: 544-546. PMID: 9707145, DOI: 10.1001/jama.280.6.544.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusInjection drug usersSelf-reported ART useAntiretroviral therapyART useDrug usersCombination therapyProtease inhibitorsRecent human immunodeficiency virusSelf-reported antiretroviral therapyInternational AIDS Society-USACurrent drug injectorsRecent antiretroviral therapyProtease inhibitor useHalf of patientsUS Public Health ServiceTriple combination therapyCommunity-based clinicsProportion of subjectsHealth care providersCurrent drug useActive drug usersCross-sectional surveyPublic health servicesInhibitor usePrevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein R, Doherty M, Monterroso E, Thomas D, Nelson K, Vlahov D. Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s11-s19. PMID: 9663618, DOI: 10.1097/00042560-199802001-00004.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersHepatitis C virus infectionC virus infectionHCV infectionVirus infectionDrug usersHCV-seronegative participantsTransmission of HCVCommunity-based outreachSecond-generation antibodiesHCV seroconversionHCV seroprevalenceCommunity outreach educationProspective studyRisk factorsSemiannual interviewsHigh riskInjecting practicesSterile syringesBivariate analysisLogistic regressionInfectionHCVCommunity Support for Needle Exchange Programs and Pharmacy Sale of Syringes: A Household Survey in Baltimore, Maryland
Keyl P, Gruskin L, Casano K, Montag H, Junge B, Vlahov D. Community Support for Needle Exchange Programs and Pharmacy Sale of Syringes: A Household Survey in Baltimore, Maryland. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1998, 18: s82-s88. PMID: 9663629, DOI: 10.1097/00042560-199802001-00015.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAttitude to HealthBaltimoreEducational StatusFamily CharacteristicsFemaleHealth Knowledge, Attitudes, PracticeHealth SurveysHIV InfectionsHumansIncomeInterviews as TopicMaleMiddle AgedMultivariate AnalysisNeedle-Exchange ProgramsPharmaciesRegression AnalysisSurveys and QuestionnairesSyringesConceptsNeedle exchange programsInjection drug useInjection drug usersDrug usersMultivariate logistic regressionContiguous census tractsHIV incidenceNeedle exchangeDrug useEligible respondentsLogistic regressionExchange programsPharmacy salesCensus populationRandom sampleCensus tractsHousehold interviewsCommunity supportCommunity attitudesBaltimoreHousehold surveyIncidenceRespondentsTractNeedle
1997
Comparison of Neuropsychological Performance between AIDS-Free Injecting Drug Users and Homosexual Men
Concha M, Selnes O, Vlahov D, Nance-Sproson T, Updike M, Royal W, Palenicek J, McArthur J. Comparison of Neuropsychological Performance between AIDS-Free Injecting Drug Users and Homosexual Men. Neuroepidemiology 1997, 16: 78-85. PMID: 9057169, DOI: 10.1159/000109674.Peer-Reviewed Original Research
1996
Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users
Manoff S, Vlahov D, Herskowitz A, Solomon L, Munoz A, Cohn S, Willoughby S, Nelson K. Human Immunodeficiency Virus Infection and Infective Endocarditis among Injecting Drug Users. Epidemiology 1996, 7: 566-570. PMID: 8899380, DOI: 10.1097/00001648-199611000-00002.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionHIV-seropositive subjectsImmunodeficiency virus infectionInfective endocarditisDrug usersCD4 cellsOdds ratioVirus infectionHistory of endocarditisRisk of endocarditisHIV-seronegative subjectsInjection drug useInjecting Drug UsersCase-control studyConditional logistic regressionRace/ethnicitySubsequent endocarditisOngoing cohortHIV infectionSerious complicationsHIV serostatusEnrollment dateLast visitCohort enrollmentEndocarditis casesAn International Collaborative Study of the Effects of Coinfection with Human T-Lymphotropic Virus Type II on Human Immunodeficiency Virus Type 1 Disease Progression in Injection Drug Users
Hershow R, Galai N, Fukuda K, Graber J, Vlahov D, Rezza G, Klein R, Jarlais D, Vitek C, Khabbaz R, Freels S, Zuckerman R, Pezzotti P, Kaplan J. An International Collaborative Study of the Effects of Coinfection with Human T-Lymphotropic Virus Type II on Human Immunodeficiency Virus Type 1 Disease Progression in Injection Drug Users. The Journal Of Infectious Diseases 1996, 174: 309-317. PMID: 8699060, DOI: 10.1093/infdis/174.2.309.Peer-Reviewed Original ResearchConceptsInjection drug usersCD4 cell percentCell percentHuman immunodeficiency virus type 1 (HIV-1) disease progressionHuman immunodeficiency virus type 1 (HIV-1) infectionDrug usersInfected injection drug usersVirus type 1 infectionHuman T-lymphotropic virus type IIHIV seroconversion datesHTLV-II infectionType 1 infectionProportional hazards modelEffect of coinfectionSeroconversion datesCohort studyHIV infectionHTLV infectionDisease progressionAIDS mortalityHTLV-IIHazards modelRate of declineInternational collaborative studyWestern blot
1995
Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users
Semba R, Caiaffa W, Graham N, Cohn S, Vlahov D. Vitamin A Deficiency and Wasting as Predictors of Mortality in Human Immunodeficiency Virus-Infected Injection Drug Users. The Journal Of Infectious Diseases 1995, 171: 1196-1202. PMID: 7751694, DOI: 10.1093/infdis/171.5.1196.Peer-Reviewed Original ResearchConceptsInjection drug usersHuman immunodeficiency virus-infected injection drug usersDrug usersPredictors of mortalityLarge prospective cohortBody mass indexHuman immunodeficiency virusCase-control studyPlasma vitamin ACD4 cellsProspective cohortHIV infectionIndependent predictorsMass indexImmunodeficiency virusLast visitRisk factorsHigh riskVitamin AAdult subjectsMortalityInfectionMean lengthWastingVitaminAge, Gender, and Other Predictors of the Wasting Syndrome among HIV-1-Infected Injecting Drug Users
Sorkin J, Boiton P, Greenblatt J, Sithisarankul P, Vlahov D, Graham N. Age, Gender, and Other Predictors of the Wasting Syndrome among HIV-1-Infected Injecting Drug Users. Epidemiology 1995, 6: 172-177. PMID: 7742405, DOI: 10.1097/00001648-199503000-00015.Peer-Reviewed Original ResearchConceptsDrug usersDrug useFemale genderHuman immunodeficiency virus-1CD4 cell levelsCD4 T lymphocytesInjecting Drug UsersCase-control studyPresence of diarrheaImmunodeficiency virus-1Independent predictorsT lymphocytesSyndromeOlder ageWasting syndromeHIVWeight lossVirus 1AgeDiarrheaCrude predictorCohortPredictorsMore yearsLower percentage
1992
Changes in T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection
Margolick J, Muñoz A, Vlahov D, Solomon L, Astemborski J, Cohn S, Nelson K. Changes in T-Lymphocyte Subsets in Intravenous Drug Users With HIV-1 Infection. JAMA 1992, 267: 1631-1636. PMID: 1347321, DOI: 10.1001/jama.1992.03480120069035.Peer-Reviewed Original ResearchConceptsSeropositive intravenous drug usersIntravenous drug usersHIV-1 infectionHIV-1-seropositive intravenous drug usersDrug usersCell countSeronegative intravenous drug usersHuman immunodeficiency virus type 1Complete blood cell countImmunodeficiency virus type 1Absolute numberCD4 cell countCD4 lymphocyte countPercentage of CD4T lymphocyte subsetsCD8 T cellsT cell subsetsCommunity-based clinicsBlood cell countTime of seroconversionVirus type 1Multivariate regression analysisUse of drugsCD4 lymphocytesCD8 lymphocytes